Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia

被引:120
|
作者
Mirza, Hussnain [1 ]
Ziegler, James [2 ]
Ford, Sara [1 ]
Padbury, James [1 ]
Tucker, Richard [1 ]
Laptook, Abbot [1 ]
机构
[1] Brown Univ, Dept Pediat, Women & Infants Hosp, Alpert Med Sch, Providence, RI USA
[2] Brown Univ, Div Pediat Cardiol, Hasbro Childrens Hosp, Alpert Med Sch, Providence, RI USA
来源
JOURNAL OF PEDIATRICS | 2014年 / 165卷 / 05期
关键词
CHRONIC LUNG-DISEASE; HYALINE-MEMBRANE DISEASE; BIRTH-WEIGHT INFANTS; ARTERY PRESSURE; SURFACTANT ERA; RISK-FACTORS; OUTCOMES; CHILDREN; PATHOGENESIS; NEWBORN;
D O I
10.1016/j.jpeds.2014.07.040
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To determine whether early pulmonary hypertension (PH) at 10-14 days of life in preterm infants is associated with bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA). Study design This was a prospective observational cohort study of infants <28 weeks' gestation. Exclusion criteria were any major anomaly, genetic syndrome, or death before the initial echocardiogram. Echocardiograms were performed between 10 and 14 days of life and at 36 weeks' PMA to assess PH. BPD and its severity were determined at 36 weeks PMA by the National Institutes of Health workshop definition. Results From March 2011 to April 2013, of 146 consecutively admitted infants <28 weeks, 120 were enrolled. One infant was excluded, 17 did not consent, and 8 died before undergoing a study echocardiogram. At 10-14 days of life, 10 infants had early PH (8%). Male sex (56% vs 40%), gestational age (26(+2) +/- 1(+2) vs 25(+6) +/- 1(+4) weeks), birth weight (837 +/- 205 g vs 763 +/- 182 g), and small for gestational age (14% vs 20%) were not significantly different among infants with no PH and early PH, respectively. Infants with early PH required >0.3 fraction of inspired oxygen by day 10 of life (70% vs 27%, P<.01). Moderate/severe BPD or death was greater among infants with early PH (90%) compared with no PH (47%, relative risk 1.9, 95% CI 1.43-2.53). Conclusion In this prospective, single-center cohort, early PH was associated with moderate/severe BPD or death at 36 weeks' PMA.
引用
收藏
页码:909 / U338
页数:7
相关论文
共 50 条
  • [41] THE PREVALENCE OF OBSTRUCTIVE APNEAS IN PRETERM INFANTS WITH AND WITHOUT BRONCHOPULMONARY DYSPLASIA
    FAJARDO, C
    ALVAREZ, J
    WONG, A
    KWIATKOWSKI, K
    RIGATTO, H
    PEDIATRIC RESEARCH, 1990, 27 (04) : A301 - A301
  • [42] Pulmonary Hypertension Specific Treatment in Infants With Bronchopulmonary Dysplasia
    Kadmon, Gili
    Schiller, Ofer
    Dagan, Tamir
    Bruckheimer, Elchanan
    Birk, Einat
    Schonfeld, Tommy
    PEDIATRIC PULMONOLOGY, 2017, 52 (01) : 77 - 83
  • [43] Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia
    Levy, Philip T.
    Levin, Jonathan
    Leeman, Kristen T.
    Mullen, Mary P.
    Hansmann, Georg
    Kourembanas, Stella
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2022, 27 (04):
  • [44] Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia
    Collaco, Joseph M.
    Romer, Lewis H.
    Stuart, Bridget D.
    Coulson, John D.
    Everett, Allen D.
    Lawson, Edward E.
    Brenner, Joel I.
    Brown, Anna T.
    Nies, Melanie K.
    Sekar, Priya
    Nogee, Lawrence M.
    McGrath-Morrow, Sharon A.
    PEDIATRIC PULMONOLOGY, 2012, 47 (11) : 1042 - 1053
  • [45] Association of MUC-5B in Pulmonary Hypertension in Preterm Babies with Bronchopulmonary Dysplasia
    Siddaiah, R.
    Ortiz, N. Fuentes
    Kitch, D.
    DiAngelo, S.
    Ojimmuo, C.
    Aluquin, V.
    Silveyra, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [46] Soluble Klotho, a biomarker and therapeutic strategy to reduce bronchopulmonary dysplasia and pulmonary hypertension in preterm infants
    Sunil Batlahally
    Andrew Franklin
    Andreas Damianos
    Jian Huang
    Pingping Chen
    Mayank Sharma
    Joanne Duara
    Divya Keerthy
    Ronald Zambrano
    Lina A. Shehadeh
    Eliana C. Martinez
    Marissa J. DeFreitas
    Shathiyah Kulandavelu
    Carolyn L. Abitbol
    Michael Freundlich
    Rosemeire M. Kanashiro-Takeuchi
    Augusto Schmidt
    Merline Benny
    Shu Wu
    Karen K. Mestan
    Karen C. Young
    Scientific Reports, 10
  • [47] Is permissive hypercapnia associated with the development of bronchopulmonary dysplasia-associated pulmonary hypertension in preterm infants?
    Bhatia, K. S.
    Nayak, A.
    Jeffcoat, S. H.
    Carlo, W. A.
    Ambalavanan, N.
    Gentle, S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369 : S421 - S422
  • [48] Achieved oxygen saturations and risk for bronchopulmonary dysplasia-associated pulmonary hypertension in preterm infants
    Gentle, S. J.
    Singh, A.
    Travers, C.
    Nakhmani, A.
    Carlo, W. A.
    Ambalavanan, N.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S231 - S232
  • [49] B-TYPE NATRIURETIC PEPTIDE AS A MARKER OF PULMONARY HYPERTENSION IN PRETERM INFANTS WITH BRONCHOPULMONARY DYSPLASIA
    Cuna, A.
    Fineberg, N.
    Sims, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 428 - 428
  • [50] Early Non-invasive Predictors of Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia in Preterm Infants
    Siddaiah, R.
    Wang, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207